Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.

Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R, Ricciardi J.

Am J Psychiatry. 1990 Sep;147(9):1209-15.

PMID:
2143637
2.

Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo.

Jenike MA, Baer L, Summergrad P, Minichiello WE, Holland A, Seymour R.

Am J Psychiatry. 1990 Jul;147(7):923-8. Erratum in: Am J Psychiatry 1990 Oct;147(10):1393.

PMID:
2192564
3.

Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.

Piccinelli M, Pini S, Bellantuono C, Wilkinson G.

Br J Psychiatry. 1995 Apr;166(4):424-43.

PMID:
7795913
4.

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.

Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC.

Arch Gen Psychiatry. 1995 Jan;52(1):53-60.

PMID:
7811162
5.

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.

Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS.

Arch Gen Psychiatry. 1989 Jan;46(1):36-44.

PMID:
2491940
6.

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.

Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS.

Arch Gen Psychiatry. 1990 Jun;47(6):577-85.

PMID:
2112374
7.

Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.

Flament MF, Bisserbe JC.

J Clin Psychiatry. 1997;58 Suppl 12:18-22. Review.

8.

Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.

Barr LC, Goodman WK, Anand A, McDougle CJ, Price LH.

Am J Psychiatry. 1997 Sep;154(9):1293-5.

PMID:
9286191
9.

Fluvoxamine treatment of obsessive-compulsive disorder.

Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R.

Am J Psychiatry. 1987 Dec;144(12):1543-8.

PMID:
3120604
10.

Pharmacologic management of obsessive-compulsive disorder.

Jackson CW, Morton WA, Lydiard RB.

South Med J. 1994 Mar;87(3):310-21.

PMID:
8134850
11.

Pharmacotherapy of obsessive compulsive disorder.

Goodman WK, McDougle CJ, Price LH.

J Clin Psychiatry. 1992 Apr;53 Suppl:29-37. Review.

PMID:
1532962
12.
13.

A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.

McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR.

J Clin Psychopharmacol. 1991 Jun;11(3):175-84.

PMID:
1820757
14.

Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.

Fineberg NA, Bullock T, Montgomery DB, Montgomery SA.

Int Clin Psychopharmacol. 1992 Jun;7 Suppl 1:43-7. Review. No abstract available.

PMID:
1517558
15.

Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.

Hollander E, DeCaria CM, Schneier FR, Schneier HA, Liebowitz MR, Klein DF.

J Clin Psychiatry. 1990 Mar;51(3):119-23.

PMID:
2106515
16.

Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.

Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffney M, Bick PA.

Psychopharmacol Bull. 1990;26(3):279-84.

PMID:
2274626
17.

Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.

den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS.

Int Clin Psychopharmacol. 1987 Jan;2(1):21-32.

PMID:
3117876
18.

A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.

Milanfranchi A, Ravagli S, Lensi P, Marazziti D, Cassano GB.

Int Clin Psychopharmacol. 1997 May;12(3):131-6.

PMID:
9248868
19.

Treatment of severe obsessive-compulsive disorder with fluvoxamine.

Price LH, Goodman WK, Charney DS, Rasmussen SA, Heninger GR.

Am J Psychiatry. 1987 Aug;144(8):1059-61.

PMID:
3111279
20.

Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.

Mundo E, Guglielmo E, Bellodi L.

Int Clin Psychopharmacol. 1998 Sep;13(5):219-24.

PMID:
9817627

Supplemental Content

Support Center